4 Amendments of Cristian-Silviu BUŞOI related to 2020/2012(INL)
Amendment 106 #
Draft opinion
Paragraph 5
Paragraph 5
5. Strongly supports the Commission in establishing a common Union AI ethical framework to counter the shortcomings caused by AI internal market fragmentation, including environmental, healthcare, and food safety applications, and to prevent AI double standards across Member States for AI developed in Union and beyond, inter alia in areas such as consumer data management, protection and privacy in smart grids, waste management, equal access to services, patient-doctor relationship standards, interpretation of data protection and privacy legislation, including their interplay with research activities and drug development, civil liability in AI-assisted public healthcare, civil liability regarding autonomous vehicles or machinery;
Amendment 124 #
Draft opinion
Paragraph 6
Paragraph 6
6. Calls for securing the full enforcement and a uniform interpretation of Union legal framework on data protection and privacy, relevant notably in the healthcare AI applications and related sensitive data, to strengthen the “Right to an explanation” foreseen in Article 22 of Regulation (EU) 2016/679 of the European Parliament and of the Council (General Data Protection Regulation, (GDPR))2 and higher interpretability requirements for high-risk AI; _________________ 2Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General Data Protection Regulation) (OJ L 119, 4.5.2016, p. 1).
Amendment 149 #
Draft opinion
Paragraph 8
Paragraph 8
8. Highlights the benefits of AI for disease prevention, treatment and control, exemplified by AI predicting the COVID19 epidemic before WHO; urges the Commission to equip ECDC in its reform, which was brought about by the COVID19 crisis, as well as EMA, with the legal framework and resources allowing for gathering necessary data independently, including, among others, AI solutions;
Amendment 166 #
Draft opinion
Paragraph 9 a (new)
Paragraph 9 a (new)
9a. Calls for securing a clearer legal remit and sufficient financing for EMA and national competent authorities for medicines to support innovation and public health aspects related to AI in the medicine lifecycle, in particular to collect and analyse real world health data that can generate additional evidence on medicinal products to support R&D and to optimise the safe and effective use of existing medicines in the interest of patients and of the European healthcare systems;